Health Canada
- Status: approved
ACE inhibitor, angiotensin receptor blocker (ACE inhibitor, angiotensin receptor blocker) regulatory status in Canada.
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. Health Canada has authorised it.
Medical University Innsbruck is the originator. The local marketing authorisation holder may differ — check the official source linked above.